Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Antivirals become a broader enterprise

Nature Biotechnology volume 25, pages 1395–1402 (2007)Cite this article

An Erratum to this article was published on 01 June 2008

This article has been updated

Small molecules have dominated antivirals for decades, but other approaches are needed and biologics could show the way.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Antiviral therapeutics market.
Figure 2

Kim Caesar

Figure 3: Market growth of in vitro diagnostics by sector from 2002–2006 with projections for 2007–2009.
Figure 4: Activation of innate immune system by TRLs.

Change history

  • 08 April 2008

    In the version of this article initially published, the name of a person quoted on p. 1399 was incorrect. The CSO of Replicor of Laval, QC, Canada, given as “Andrew Toussaint” should be “Andrew Vaillant.” The error has been corrected in the HTML and PDF versions of the article.

Author information

Author notes

  1. Jeffrey L. Fox is a contributing writer for Nature Biotechnology.

Authors
  1. Jeffrey L Fox
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, J. Antivirals become a broader enterprise. Nat Biotechnol 25, 1395–1402 (2007). https://doi.org/10.1038/nbt1207-1395

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1207-1395

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing